Endometrial cancer is platinum-resistant if it continues to grow or comes back within 6 months of treatment with carboplatin or cisplatin. The cancer may spread to areas outside your endometrium ...

However, isolated pelvic node recurrence is rare in endometrial cancer patients (2%) and, in most cases with pelvic node recurrence, distant metastases are also seen. [52] The use of pelvic ...

But when left untreated, endometrial cancer may start to spread through the wall of the uterus and into the pelvis, causing ...

A coroner found there were "missed opportunities" to treat a 38-year-old woman with cancer. Carla Smith, 38, who died on 7 ...

In a randomized clinical trial, researchers from Huntsman Cancer Institute at the University of Utah (the U) have found that ...

A thorough medical history and physical exam A pelvic exam and Pap test Imaging tests such as a transvaginal ultrasound, X-ray, or computed tomography (CT or CAT) scan to not only diagnose uterine ...

In most cases, we only recommend other therapies — such as chemotherapy, hormone therapy, or radiation therapy — if the cancer has spread into the deep uterine muscle layer or beyond. We also offer ...

Researchers have found that fewer sessions of higher dose vaginal cuff brachytherapy work just as well as more frequent, lower-dose treatments for endometrial cancer patients.

The high prevalence of sarcopenia in patients with ovarian and endometrial cancers underscores the importance of early ...

The results of a multisite clinical trial overseen by University of Colorado Cancer Center member Bradley Corr, MD, could offer new hope to patients with metastatic and recurrent uterine cancer ...